Γκαμπαπεντίνη (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Γκαμπαπεντίνη" in Greek language version.

refsWebsite

Global rank Greek rank

87nih.gov

4^th place

63doi.org

2^nd place

3^rd place

15books.google.com

3^rd place

6^th place

12web.archive.org

1^st place

5drugs.com

399^th place

130^th place

3archive.org

6^th place

5^th place

3fda.gov

447^th place

368^th place

2clincalc.com

3,912^th place

594^th place

2harvard.edu

18^th place

57^th place

2worldcat.org

5^th place

8^th place

2gov.uk

432^nd place

530^th place

2springer.com

274^th place

297^th place

2medscape.com

719^th place

579^th place

1reuters.com

49^th place

98^th place

1torvergata.it

low place

1ox.ac.uk

613^th place

675^th place

1va.gov

4,581^st place

low place

1scielo.br

1,606^th place

1,420^th place

1ky.gov

4,208^th place

low place

1michigan.gov

4,936^th place

9,868^th place

1wvlegislature.gov

low place

1tn.gov

6,243^rd place

low place

1alabamapublichealth.gov

low place

1nursingnotes.co.uk

low place

1publishing.service.gov.uk

1,877^th place

4,283^rd place

1bmj.com

1,226^th place

730^th place

1psychiatria-danubina.com

low place

1goodrx.com

low place

alabamapublichealth.gov

«Pharmacy Division | Alabama Department of Public Health (ADPH)». www.alabamapublichealth.gov. Ανακτήθηκε στις 30 Μαΐου 2020.

archive.org

«The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines». Headache 52 (6): 930–45. June 2012. doi:10.1111/j.1526-4610.2012.02185.x. PMID 22671714. https://archive.org/details/sim_headache_2012-06_52_6/page/930.
«Clinical pharmacokinetics of XP13512, a novel transported prodrug of gabapentin». Journal of Clinical Pharmacology 48 (12): 1378–88. December 2008. doi:10.1177/0091270008322909. PMID 18827074. https://archive.org/details/sim_journal-of-clinical-pharmacology_2008-12_48_12/page/1378.
«Gabapentin: pharmacology and its use in pain management». Anaesthesia 57 (5): 451–62. May 2002. doi:10.1046/j.0003-2409.2001.02399.x. PMID 11966555. https://archive.org/details/sim_anaesthesia_2002-05_57_5/page/451.

bmj.com

Mayor, Susan (2018-10-16). «Pregabalin and gabapentin become controlled drugs to cut deaths from misuse». British Medical Journal 363: k4364. doi:10.1136/bmj.k4364. ISSN 0959-8138. PMID 30327316. https://www.bmj.com/content/363/bmj.k4364.

books.google.com

Sneader, Walter (2005). Drug Discovery: A History. John Wiley & Sons. σελίδες 219–220. ISBN 978-0-470-01552-0.
Pitkänen, Asla· Schwartzkroin, Philip A. (2005). Models of Seizures and Epilepsy. Burlington: Elsevier. σελ. 539. ISBN 978-0-08-045702-4.
Sobel, Stephen V. (5 Νοεμβρίου 2012). Successful Psychopharmacology: Evidence-Based Treatment Solutions for Achieving Remission. W. W. Norton. σελ. 124. ISBN 978-0-393-70857-8.
Reynolds, D. John· Coleman, Jamie (10 Νοεμβρίου 2011). Oxford Handbook of Practical Drug Therapy. Oxford University Press. σελ. 765. ISBN 978-0-19-956285-5.
Edinger, Jack D. (2013). Insomnia, an Issue of Sleep Medicine Clinics. Elsevier Health Sciences. σελ. 339. ISBN 978-0-323-18872-2.
Morin, Charles M.· Espie, Colin A. (2 Φεβρουαρίου 2012). The Oxford Handbook of Sleep and Sleep Disorders. Oxford University Press. σελ. 544. ISBN 978-0-19-970442-2.
Aronson, Jeffrey K (4 Μαρτίου 2014). Side Effects of Drugs Annual: A worldwide yearly survey of new data in adverse drug reactions. Newnes. σελ. 137. ISBN 978-0-444-62636-3.
American Psychiatric Association (22 Μαΐου 2013). The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition.: DSM 5. ISBN 9780890425572.
Benzon, Honorio· Rathmell, James P. (11 Σεπτεμβρίου 2013). Practical Management of Pain. Elsevier Health Sciences. σελ. 1006. ISBN 978-0-323-17080-2.
Kaye, Alan D. (5 Ιουνίου 2017). Pharmacology, An Issue of Anesthesiology Clinics E-Book. Elsevier Health Sciences. σελίδες 98–. ISBN 978-0-323-52998-3.
Wyllie, Elaine· Cascino, Gregory D. (17 Φεβρουαρίου 2012). Wyllie's Treatment of Epilepsy: Principles and Practice. Lippincott Williams & Wilkins. σελ. 423. ISBN 978-1-4511-5348-4.
Wheless, James W.· Willmore, James (2009). Advanced Therapy in Epilepsy. PMPH-USA. σελίδες 302–. ISBN 978-1-60795-004-2.
Johnson, Douglas S.· Li, Jie Jack (26 Φεβρουαρίου 2013). The Art of Drug Synthesis. John Wiley & Sons. σελίδες 13–. ISBN 978-1-118-67846-6.
Li, Jie Jack (2014). Blockbuster Drugs: The Rise and Fall of the Pharmaceutical Industry. OUP USA. σελίδες 158–. ISBN 978-0-19-973768-0.
Reed, Diana (2 Μαρτίου 2012). The Other End of the Stethoscope: The Physician's Perspective on the Health Care Crisis. AuthorHouse. σελίδες 63–. ISBN 978-1-4685-4410-7.

clincalc.com

«The Top 300 of 2020». ClinCalc. Ανακτήθηκε στις 11 Απριλίου 2020.
«Gabapentin - Drug Usage Statistics». ClinCalc. 23 Δεκεμβρίου 2019. Ανακτήθηκε στις 11 Απριλίου 2020.

doi.org

dx.doi.org

«Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy». Drugs 46 (3): 409–427. September 1993. doi:10.2165/00003495-199346030-00007. PMID 7693432.
«Restless legs syndrome: clinical presentation diagnosis and treatment». Sleep Medicine 16 (6): 678–90. June 2015. doi:10.1016/j.sleep.2015.03.002. PMID 25979181.
«EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision». European Journal of Neurology 17 (9): 1113–e88. September 2010. doi:10.1111/j.1468-1331.2010.02999.x. PMID 20402746.
«Gabapentin for chronic neuropathic pain in adults». The Cochrane Database of Systematic Reviews 6: CD007938. June 2017. doi:10.1002/14651858.CD007938.pub4. PMID 28597471.
«2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use». Expert Review of Neurotherapeutics 16 (11): 1263–1277. November 2016. doi:10.1080/14737175.2016.1202764. PMID 27345098.
«Acute modulation of calcium currents and synaptic transmission by gabapentinoids». Channels 4 (6): 490–6. 2010. doi:10.4161/chan.4.6.12864. PMID 21150315.
«Safeguarding patient welfare: who's in charge?». Annals of Internal Medicine 145 (4): 305–7. August 2006. doi:10.7326/0003-4819-145-4-200608150-00013. PMID 16908923.
«Mechanisms of the gabapentinoids and α 2 δ-1 calcium channel subunit in neuropathic pain». Pharmacology Research & Perspectives 4 (2): e00205. April 2016. doi:10.1002/prp2.205. PMID 27069626.
«Gabapentin misuse, abuse and diversion: a systematic review». Addiction 111 (7): 1160–74. July 2016. doi:10.1111/add.13324. PMID 27265421.
«Failure of absorption of gabapentin after rectal administration». Epilepsia 38 (11): 1242–4. November 1997. doi:10.1111/j.1528-1157.1997.tb01223.x. PMID 9579927.
«Outcome reporting in industry-sponsored trials of gabapentin for off-label use». The New England Journal of Medicine 361 (20): 1963–71. November 2009. doi:10.1056/NEJMsa0906126. PMID 19907043.
«Management of focal-onset seizures: an update on drug treatment». Drugs 66 (13): 1701–25. 2006. doi:10.2165/00003495-200666130-00004. PMID 16978035.
«Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society». Epilepsia 45 (5): 401–9. May 2004. doi:10.1111/j.0013-9580.2004.06204.x. PMID 15101821.
«Anticonvulsants in the treatment of low back pain and lumbar radicular pain: a systematic review and meta-analysis». CMAJ 190 (26): E786–E793. July 2018. doi:10.1503/cmaj.171333. PMID 29970367.
Mack, Alicia (2003). «Examination of the evidence for off-label use of gabapentin». Journal of Managed Care Pharmacy 9 (6): 559–568. doi:10.18553/jmcp.2003.9.6.559. PMID 14664664.
«Benefits and safety of gabapentinoids in chronic low back pain: A systematic review and meta-analysis of randomized controlled trials». PLOS Medicine 14 (8): e1002369. August 2017. doi:10.1371/journal.pmed.1002369. PMID 28809936.
«Gabapentin for the treatment of cancer-related pain syndromes». Reviews on Recent Clinical Trials 5 (3): 174–8. September 2010. doi:10.2174/157488710792007310. PMID 20482492.
«Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials». PLOS ONE 5 (12): e14433. December 2010. doi:10.1371/journal.pone.0014433. PMID 21203440. Bibcode: 2010PLoSO...514433P.
«Treatment of complex regional pain syndrome: a review of the evidence». Canadian Journal of Anaesthesia 57 (2): 149–66. February 2010. doi:10.1007/s12630-009-9237-0. PMID 20054678.
«Gabapentin and pregabalin for the acute post-operative pain management. A systematic-narrative review of the recent clinical evidences». Current Drug Targets 10 (8): 716–33. August 2009. doi:10.2174/138945009788982513. PMID 19702520. https://art.torvergata.it/bitstream/2108/10507/1/Dauri_CDT%2c%202009.pdf.
«A Meta-Analysis on the Use of Gabapentinoids for the Treatment of Acute Postoperative Pain Following Total Knee Arthroplasty». The Journal of Bone and Joint Surgery. American Volume 98 (16): 1340–50. August 2016. doi:10.2106/jbjs.15.01202. PMID 27535436. Αρχειοθετήθηκε από το πρωτότυπο στις 2020-09-29. https://web.archive.org/web/20200929012600/https://ora.ox.ac.uk/objects/uuid:cbe29197-14a9-47dc-b961-2ad3e24fd1c0. Ανακτήθηκε στις 2020-09-21.
«The evidence for pharmacological treatment of neuropathic pain». Pain 150 (3): 573–81. September 2010. doi:10.1016/j.pain.2010.06.019. PMID 20705215. https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0029530/.
«Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis». The Lancet. Neurology 14 (2): 162–73. February 2015. doi:10.1016/S1474-4422(14)70251-0. PMID 25575710. «There was no evidence for a dose-response effect.».
«The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines». Headache 52 (6): 930–45. June 2012. doi:10.1111/j.1526-4610.2012.02185.x. PMID 22671714. https://archive.org/details/sim_headache_2012-06_52_6/page/930.
«Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults». The Cochrane Database of Systematic Reviews 6 (6): CD010609. June 2013. doi:10.1002/14651858.CD010609. PMID 23797675.
«Gabapentin Therapy in Psychiatric Disorders: A Systematic Review». The Primary Care Companion for CNS Disorders 17 (5). 2015. doi:10.4088/PCC.15r01821. PMID 26835178.
«Gabapentin for smoking cessation: a preliminary investigation of efficacy». Nicotine & Tobacco Research 9 (2): 291–8. February 2007. doi:10.1080/14622200601080307. PMID 17365760.
«Gabapentin for smoking cessation». Nicotine & Tobacco Research 12 (3): 300–4. March 2010. doi:10.1093/ntr/ntp195. PMID 20081039.
«Pharmacotherapies for cannabis dependence». The Cochrane Database of Systematic Reviews 1: CD008940. January 2019. doi:10.1002/14651858.CD008940.pub3. PMID 30687936.
«Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis». Clinical Therapeutics 31 (2): 221–35. February 2009. doi:10.1016/j.clinthera.2009.02.006. PMID 19302896.
«Non-hormonal therapy of post-menopausal vasomotor symptoms: a structured evidence-based review». Archives of Gynecology and Obstetrics 276 (5): 463–9. November 2007. doi:10.1007/s00404-007-0390-9. PMID 17593379.
«Non-hormonal interventions for hot flushes in women with a history of breast cancer». The Cochrane Database of Systematic Reviews 131 (9): 141. September 2010. doi:10.1002/14651858.CD004923.pub2. PMID 20824841. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802013000200141.
«Gabapentin enacarbil: in patients with restless legs syndrome». CNS Drugs 26 (12): 1073–83. December 2012. doi:10.1007/s40263-012-0020-3. PMID 23179641.
«Pruritus and renal failure». Seminars in Cutaneous Medicine and Surgery 30 (2): 99–100. June 2011. doi:10.1016/j.sder.2011.04.005. PMID 21767770.
«Gabapentin for pruritus in palliative care». The American Journal of Hospice & Palliative Care 30 (2): 192–6. March 2013. doi:10.1177/1049909112445464. PMID 22556282.
«The treatment of tremor». Neurotherapeutics 11 (1): 128–38. January 2014. doi:10.1007/s13311-013-0230-5. PMID 24142589.
«Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology». Neurology 77 (19): 1752–5. November 2011. doi:10.1212/WNL.0b013e318236f0fd. PMID 22013182.
«Pharmacological management of essential tremor». Drugs 70 (17): 2215–28. December 2010. doi:10.2165/11538180-000000000-00000. PMID 21080739.
«Gabapentin for tinnitus: a systematic review». American Journal of Audiology 20 (2): 151–8. December 2011. doi:10.1044/1059-0889(2011/10-0041). PMID 21940981.
«Review about gabapentin misuse, interactions, contraindications and side effects». Journal of Experimental Pharmacology 9: 13–21. 2017. doi:10.2147/JEP.S124391. PMID 28223849.
«Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death». JAMA 303 (14): 1401–9. April 2010. doi:10.1001/jama.2010.410. PMID 20388896.
«The association between gabapentin and suicidality in bipolar patients». International Clinical Psychopharmacology 34 (1): 27–32. January 2019. doi:10.1097/YIC.0000000000000242. PMID 30383553.
Mayor, Susan (2018-10-16). «Pregabalin and gabapentin become controlled drugs to cut deaths from misuse». British Medical Journal 363: k4364. doi:10.1136/bmj.k4364. ISSN 0959-8138. PMID 30327316. https://www.bmj.com/content/363/bmj.k4364.
«On the addictive power of gabapentinoids: a mini-review». Psychiatria Danubina 30 (2): 142–149. June 2018. doi:10.24869/psyd.2018.142. PMID 29930223. http://www.psychiatria-danubina.com/UserDocsImages/pdf/dnb_vol30_no2/dnb_vol30_no2_142.pdf.
«How addictive are gabapentin and pregabalin? A systematic review». European Neuropsychopharmacology 27 (12): 1185–1215. December 2017. doi:10.1016/j.euroneuro.2017.08.430. PMID 28988943.
«Gabapentin: Abuse, Dependence, and Withdrawal». The Annals of Pharmacotherapy 50 (3): 229–33. March 2016. doi:10.1177/1060028015620800. PMID 26721643.
«[On the risk of dependence on gabapentinoids]» (στα German). Fortschritte der Neurologie-Psychiatrie 86 (2): 82–105. February 2018. doi:10.1055/s-0043-122392. PMID 29179227.
«The mechanisms of action of gabapentin and pregabalin». Current Opinion in Pharmacology 6 (1): 108–13. February 2006. doi:10.1016/j.coph.2005.11.003. PMID 16376147.
«The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities?». Trends Pharmacol. Sci. 34 (6): 332–9. 2013. doi:10.1016/j.tips.2013.04.001. PMID 23642658.
«Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission». Trends in Pharmacological Sciences 28 (2): 75–82. February 2007. doi:10.1016/j.tips.2006.12.006. PMID 17222465.
«Functional biology of the alpha(2)delta subunits of voltage-gated calcium channels». Trends in Pharmacological Sciences 28 (5): 220–8. May 2007. doi:10.1016/j.tips.2007.03.005. PMID 17403543.
«Transport of gabapentin by LAT1 (SLC7A5)». Biochemical Pharmacology 85 (11): 1672–83. June 2013. doi:10.1016/j.bcp.2013.03.022. PMID 23567998.
«Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2». European Journal of Pharmaceutical Sciences 35 (3): 161–74. October 2008. doi:10.1016/j.ejps.2008.06.015. PMID 18656534.
«A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin». Clinical Pharmacokinetics 49 (10): 661–9. October 2010. doi:10.2165/11536200-000000000-00000. PMID 20818832.
«Gabapentin enacarbil - clinical efficacy in restless legs syndrome». Neuropsychiatric Disease and Treatment 6: 151–8. May 2010. doi:10.2147/NDT.S5712. PMID 20505847.
«Clinical pharmacokinetics of XP13512, a novel transported prodrug of gabapentin». Journal of Clinical Pharmacology 48 (12): 1378–88. December 2008. doi:10.1177/0091270008322909. PMID 18827074. https://archive.org/details/sim_journal-of-clinical-pharmacology_2008-12_48_12/page/1378.
«Molecular determinants of blood-brain barrier permeation». Therapeutic Delivery 6 (8): 961–71. 2015. doi:10.4155/tde.15.32. PMID 26305616.
«Prodrug approaches for enhancing the bioavailability of drugs with low solubility». Chemistry & Biodiversity 6 (11): 2071–83. November 2009. doi:10.1002/cbdv.200900114. PMID 19937841.
«Selective expression of the large neutral amino acid transporter at the blood-brain barrier». Proceedings of the National Academy of Sciences of the United States of America 96 (21): 12079–84. October 1999. doi:10.1073/pnas.96.21.12079. PMID 10518579. Bibcode: 1999PNAS...9612079B.
«An update on GABA analogs for CNS drug discovery». Recent Patents on CNS Drug Discovery 1 (1): 113–8. January 2006. doi:10.2174/157488906775245291. PMID 18221197.
«Gabapentin: pharmacology and its use in pain management». Anaesthesia 57 (5): 451–62. May 2002. doi:10.1046/j.0003-2409.2001.02399.x. PMID 11966555. https://archive.org/details/sim_anaesthesia_2002-05_57_5/page/451.
«Conformationally restricted GABA analogs: from rigid carbocycles to cage hydrocarbons». Future Medicinal Chemistry 3 (2): 223–41. February 2011. doi:10.4155/fmc.10.287. PMID 21428817.
«Once-daily gastroretentive gabapentin for the management of postherpetic neuralgia: an update for clinicians». Therapeutic Advances in Chronic Disease 3 (5): 211–8. September 2012. doi:10.1177/2040622312452905. PMID 23342236.

drugs.com

«Gabapentin Use During Pregnancy». Drugs.com. 2 Δεκεμβρίου 2019. Ανακτήθηκε στις 21 Δεκεμβρίου 2019.
«Gabapentin». The American Society of Health-System Pharmacists. Αρχειοθετήθηκε από το πρωτότυπο στις 19 Αυγούστου 2017. Ανακτήθηκε στις 23 Οκτωβρίου 2015.
«Gabapentin». The American Society of Health-System Pharmacists. Αρχειοθετήθηκε από το πρωτότυπο στις 19 Αυγούστου 2017. Ανακτήθηκε στις 23 Οκτωβρίου 2015.
«Gabapentin Pregnancy and Breastfeeding Warnings». Αρχειοθετήθηκε από το πρωτότυπο στις 29 Αυγούστου 2017. Ανακτήθηκε στις 13 Μαρτίου 2016.
«Gabapentin». The American Society of Health-System Pharmacists. Αρχειοθετήθηκε από το πρωτότυπο στις 12 Ιανουαρίου 2011. Ανακτήθηκε στις 3 Απριλίου 2011.

fda.gov

«Suicidal Behavior and Ideation and Antiepileptic Drugs». U.S. Food and Drug Administration (FDA). Αρχειοθετήθηκε από το πρωτότυπο στις 1 Αυγούστου 2009.
«FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR)». U.S. Food and Drug Administration (FDA). 19 Δεκεμβρίου 2019. Αρχειοθετήθηκε από το πρωτότυπο στις 22 Δεκεμβρίου 2019. Ανακτήθηκε στις 21 Δεκεμβρίου 2019. Αυτό το λήμμα περιλαμβάνει κείμενο από αυτή την πηγή, που είναι κοινό κτήμα.
«FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR) When used with CNS depressants or in patients with lung problems». 19 Δεκεμβρίου 2019. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 22 Δεκεμβρίου 2019. Ανακτήθηκε στις 22 Δεκεμβρίου 2019. Αυτό το λήμμα περιλαμβάνει κείμενο από αυτή την πηγή, που είναι κοινό κτήμα.

goodrx.com

Orrange, Sharon (31 Μαΐου 2013). «Yabba Dabba Gabapentin: Are Gralise and Horizant Worth the Cost?». GoodRx, Inc. Αρχειοθετήθηκε από το πρωτότυπο στις 23 Ιουνίου 2018. Ανακτήθηκε στις 22 Ιουνίου 2018.

gov.uk

«Pregabalin and gabapentin: proposal to schedule under the Misuse of Drugs Regulations 2001». GOV.UK. 10 Νοεμβρίου 2017. Ανακτήθηκε στις 2 Απριλίου 2020.
«Pregabalin and gabapentin to be controlled as Class C drugs». GOV.UK. 15 Οκτωβρίου 2018. Ανακτήθηκε στις 2 Απριλίου 2020.

harvard.edu

adsabs.harvard.edu

«Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials». PLOS ONE 5 (12): e14433. December 2010. doi:10.1371/journal.pone.0014433. PMID 21203440. Bibcode: 2010PLoSO...514433P.
«Selective expression of the large neutral amino acid transporter at the blood-brain barrier». Proceedings of the National Academy of Sciences of the United States of America 96 (21): 12079–84. October 1999. doi:10.1073/pnas.96.21.12079. PMID 10518579. Bibcode: 1999PNAS...9612079B.

ky.gov

pharmacy.ky.gov

«Important Notice: Gabapentin Becomes a Schedule 5 Controlled Substance in Kentucky» (PDF). Kentucky State Board of Pharmacy. Μαρτίου 2017. Ανακτήθηκε στις 18 Ιουνίου 2018.

medscape.com

reference.medscape.com

«Neurontin, Gralise (gabapentin) dosing, indications, interactions, adverse effects, and more». Medscape Reference. WebMD. Αρχειοθετήθηκε από το πρωτότυπο στις 16 Δεκεμβρίου 2014. Ανακτήθηκε στις 6 Απριλίου 2014.

medscape.com

Jeffrey, Susan. «FDA Approves Gabapentin Enacarbil for Postherpetic Neuralgia». Medscape.

michigan.gov

«Gabapentin Scheduled as Controlled Substance to help with State's Opioid Epidemic». Ανακτήθηκε στις 16 Απριλίου 2019.

nih.gov

ncbi.nlm.nih.gov

«Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy». Drugs 46 (3): 409–427. September 1993. doi:10.2165/00003495-199346030-00007. PMID 7693432.
«Restless legs syndrome: clinical presentation diagnosis and treatment». Sleep Medicine 16 (6): 678–90. June 2015. doi:10.1016/j.sleep.2015.03.002. PMID 25979181.
«EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision». European Journal of Neurology 17 (9): 1113–e88. September 2010. doi:10.1111/j.1468-1331.2010.02999.x. PMID 20402746.
«Gabapentin for chronic neuropathic pain in adults». The Cochrane Database of Systematic Reviews 6: CD007938. June 2017. doi:10.1002/14651858.CD007938.pub4. PMID 28597471.
«2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use». Expert Review of Neurotherapeutics 16 (11): 1263–1277. November 2016. doi:10.1080/14737175.2016.1202764. PMID 27345098.
«Acute modulation of calcium currents and synaptic transmission by gabapentinoids». Channels 4 (6): 490–6. 2010. doi:10.4161/chan.4.6.12864. PMID 21150315.
«Safeguarding patient welfare: who's in charge?». Annals of Internal Medicine 145 (4): 305–7. August 2006. doi:10.7326/0003-4819-145-4-200608150-00013. PMID 16908923.
«Mechanisms of the gabapentinoids and α 2 δ-1 calcium channel subunit in neuropathic pain». Pharmacology Research & Perspectives 4 (2): e00205. April 2016. doi:10.1002/prp2.205. PMID 27069626.
«Gabapentin misuse, abuse and diversion: a systematic review». Addiction 111 (7): 1160–74. July 2016. doi:10.1111/add.13324. PMID 27265421.
«Failure of absorption of gabapentin after rectal administration». Epilepsia 38 (11): 1242–4. November 1997. doi:10.1111/j.1528-1157.1997.tb01223.x. PMID 9579927.
«Outcome reporting in industry-sponsored trials of gabapentin for off-label use». The New England Journal of Medicine 361 (20): 1963–71. November 2009. doi:10.1056/NEJMsa0906126. PMID 19907043.
«Management of focal-onset seizures: an update on drug treatment». Drugs 66 (13): 1701–25. 2006. doi:10.2165/00003495-200666130-00004. PMID 16978035.
«Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society». Epilepsia 45 (5): 401–9. May 2004. doi:10.1111/j.0013-9580.2004.06204.x. PMID 15101821.
«Anticonvulsants in the treatment of low back pain and lumbar radicular pain: a systematic review and meta-analysis». CMAJ 190 (26): E786–E793. July 2018. doi:10.1503/cmaj.171333. PMID 29970367.
Mack, Alicia (2003). «Examination of the evidence for off-label use of gabapentin». Journal of Managed Care Pharmacy 9 (6): 559–568. doi:10.18553/jmcp.2003.9.6.559. PMID 14664664.
«Benefits and safety of gabapentinoids in chronic low back pain: A systematic review and meta-analysis of randomized controlled trials». PLOS Medicine 14 (8): e1002369. August 2017. doi:10.1371/journal.pmed.1002369. PMID 28809936.
«Gabapentin for the treatment of cancer-related pain syndromes». Reviews on Recent Clinical Trials 5 (3): 174–8. September 2010. doi:10.2174/157488710792007310. PMID 20482492.
«Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials». PLOS ONE 5 (12): e14433. December 2010. doi:10.1371/journal.pone.0014433. PMID 21203440. Bibcode: 2010PLoSO...514433P.
«Treatment of complex regional pain syndrome: a review of the evidence». Canadian Journal of Anaesthesia 57 (2): 149–66. February 2010. doi:10.1007/s12630-009-9237-0. PMID 20054678.
«Gabapentin and pregabalin for the acute post-operative pain management. A systematic-narrative review of the recent clinical evidences». Current Drug Targets 10 (8): 716–33. August 2009. doi:10.2174/138945009788982513. PMID 19702520. https://art.torvergata.it/bitstream/2108/10507/1/Dauri_CDT%2c%202009.pdf.
«A Meta-Analysis on the Use of Gabapentinoids for the Treatment of Acute Postoperative Pain Following Total Knee Arthroplasty». The Journal of Bone and Joint Surgery. American Volume 98 (16): 1340–50. August 2016. doi:10.2106/jbjs.15.01202. PMID 27535436. Αρχειοθετήθηκε από το πρωτότυπο στις 2020-09-29. https://web.archive.org/web/20200929012600/https://ora.ox.ac.uk/objects/uuid:cbe29197-14a9-47dc-b961-2ad3e24fd1c0. Ανακτήθηκε στις 2020-09-21.
«The evidence for pharmacological treatment of neuropathic pain». Pain 150 (3): 573–81. September 2010. doi:10.1016/j.pain.2010.06.019. PMID 20705215. https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0029530/.
«Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis». The Lancet. Neurology 14 (2): 162–73. February 2015. doi:10.1016/S1474-4422(14)70251-0. PMID 25575710. «There was no evidence for a dose-response effect.».
«The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines». Headache 52 (6): 930–45. June 2012. doi:10.1111/j.1526-4610.2012.02185.x. PMID 22671714. https://archive.org/details/sim_headache_2012-06_52_6/page/930.
«Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults». The Cochrane Database of Systematic Reviews 6 (6): CD010609. June 2013. doi:10.1002/14651858.CD010609. PMID 23797675.
«Outpatient management of alcohol withdrawal syndrome». American Family Physician 88 (9): 589–95. November 2013. PMID 24364635.
«Gabapentin Therapy in Psychiatric Disorders: A Systematic Review». The Primary Care Companion for CNS Disorders 17 (5). 2015. doi:10.4088/PCC.15r01821. PMID 26835178.
«Gabapentin for smoking cessation: a preliminary investigation of efficacy». Nicotine & Tobacco Research 9 (2): 291–8. February 2007. doi:10.1080/14622200601080307. PMID 17365760.
«Gabapentin for smoking cessation». Nicotine & Tobacco Research 12 (3): 300–4. March 2010. doi:10.1093/ntr/ntp195. PMID 20081039.
«Pharmacotherapies for cannabis dependence». The Cochrane Database of Systematic Reviews 1: CD008940. January 2019. doi:10.1002/14651858.CD008940.pub3. PMID 30687936.
«Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: a systematic review and meta-analysis». Clinical Therapeutics 31 (2): 221–35. February 2009. doi:10.1016/j.clinthera.2009.02.006. PMID 19302896.
«Non-hormonal therapy of post-menopausal vasomotor symptoms: a structured evidence-based review». Archives of Gynecology and Obstetrics 276 (5): 463–9. November 2007. doi:10.1007/s00404-007-0390-9. PMID 17593379.
«Non-hormonal interventions for hot flushes in women with a history of breast cancer». The Cochrane Database of Systematic Reviews 131 (9): 141. September 2010. doi:10.1002/14651858.CD004923.pub2. PMID 20824841. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802013000200141.
«Gabapentin enacarbil: in patients with restless legs syndrome». CNS Drugs 26 (12): 1073–83. December 2012. doi:10.1007/s40263-012-0020-3. PMID 23179641.
«Drugs for chronic insomnia». The Medical Letter on Drugs and Therapeutics 60 (1562): 201–205. 17 December 2018. ISSN 1523-2859. PMID 30625122.
«Pruritus and renal failure». Seminars in Cutaneous Medicine and Surgery 30 (2): 99–100. June 2011. doi:10.1016/j.sder.2011.04.005. PMID 21767770.
«Gabapentin for pruritus in palliative care». The American Journal of Hospice & Palliative Care 30 (2): 192–6. March 2013. doi:10.1177/1049909112445464. PMID 22556282.
«The treatment of tremor». Neurotherapeutics 11 (1): 128–38. January 2014. doi:10.1007/s13311-013-0230-5. PMID 24142589.
«Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology». Neurology 77 (19): 1752–5. November 2011. doi:10.1212/WNL.0b013e318236f0fd. PMID 22013182.
«Pharmacological management of essential tremor». Drugs 70 (17): 2215–28. December 2010. doi:10.2165/11538180-000000000-00000. PMID 21080739.
«Gabapentin for tinnitus: a systematic review». American Journal of Audiology 20 (2): 151–8. December 2011. doi:10.1044/1059-0889(2011/10-0041). PMID 21940981.
«Review about gabapentin misuse, interactions, contraindications and side effects». Journal of Experimental Pharmacology 9: 13–21. 2017. doi:10.2147/JEP.S124391. PMID 28223849.
«Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death». JAMA 303 (14): 1401–9. April 2010. doi:10.1001/jama.2010.410. PMID 20388896.
«The association between gabapentin and suicidality in bipolar patients». International Clinical Psychopharmacology 34 (1): 27–32. January 2019. doi:10.1097/YIC.0000000000000242. PMID 30383553.
Mayor, Susan (2018-10-16). «Pregabalin and gabapentin become controlled drugs to cut deaths from misuse». British Medical Journal 363: k4364. doi:10.1136/bmj.k4364. ISSN 0959-8138. PMID 30327316. https://www.bmj.com/content/363/bmj.k4364.
«On the addictive power of gabapentinoids: a mini-review». Psychiatria Danubina 30 (2): 142–149. June 2018. doi:10.24869/psyd.2018.142. PMID 29930223. http://www.psychiatria-danubina.com/UserDocsImages/pdf/dnb_vol30_no2/dnb_vol30_no2_142.pdf.
«How addictive are gabapentin and pregabalin? A systematic review». European Neuropsychopharmacology 27 (12): 1185–1215. December 2017. doi:10.1016/j.euroneuro.2017.08.430. PMID 28988943.
«Gabapentin: Abuse, Dependence, and Withdrawal». The Annals of Pharmacotherapy 50 (3): 229–33. March 2016. doi:10.1177/1060028015620800. PMID 26721643.
«[On the risk of dependence on gabapentinoids]» (στα German). Fortschritte der Neurologie-Psychiatrie 86 (2): 82–105. February 2018. doi:10.1055/s-0043-122392. PMID 29179227.
«The mechanisms of action of gabapentin and pregabalin». Current Opinion in Pharmacology 6 (1): 108–13. February 2006. doi:10.1016/j.coph.2005.11.003. PMID 16376147.
«The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities?». Trends Pharmacol. Sci. 34 (6): 332–9. 2013. doi:10.1016/j.tips.2013.04.001. PMID 23642658.
«Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission». Trends in Pharmacological Sciences 28 (2): 75–82. February 2007. doi:10.1016/j.tips.2006.12.006. PMID 17222465.
«Functional biology of the alpha(2)delta subunits of voltage-gated calcium channels». Trends in Pharmacological Sciences 28 (5): 220–8. May 2007. doi:10.1016/j.tips.2007.03.005. PMID 17403543.
«Transport of gabapentin by LAT1 (SLC7A5)». Biochemical Pharmacology 85 (11): 1672–83. June 2013. doi:10.1016/j.bcp.2013.03.022. PMID 23567998.
«Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2». European Journal of Pharmaceutical Sciences 35 (3): 161–74. October 2008. doi:10.1016/j.ejps.2008.06.015. PMID 18656534.
«A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin». Clinical Pharmacokinetics 49 (10): 661–9. October 2010. doi:10.2165/11536200-000000000-00000. PMID 20818832.
«Gabapentin enacarbil - clinical efficacy in restless legs syndrome». Neuropsychiatric Disease and Treatment 6: 151–8. May 2010. doi:10.2147/NDT.S5712. PMID 20505847.
«The Useage of Opioids and their Adverse Effects in Gastrointestinal Practice: A Review». Middle East Journal of Digestive Diseases 5 (1): 5–16. January 2013. PMID 24829664.
«Clinical pharmacokinetics of XP13512, a novel transported prodrug of gabapentin». Journal of Clinical Pharmacology 48 (12): 1378–88. December 2008. doi:10.1177/0091270008322909. PMID 18827074. https://archive.org/details/sim_journal-of-clinical-pharmacology_2008-12_48_12/page/1378.
«Molecular determinants of blood-brain barrier permeation». Therapeutic Delivery 6 (8): 961–71. 2015. doi:10.4155/tde.15.32. PMID 26305616.
«Prodrug approaches for enhancing the bioavailability of drugs with low solubility». Chemistry & Biodiversity 6 (11): 2071–83. November 2009. doi:10.1002/cbdv.200900114. PMID 19937841.
«Selective expression of the large neutral amino acid transporter at the blood-brain barrier». Proceedings of the National Academy of Sciences of the United States of America 96 (21): 12079–84. October 1999. doi:10.1073/pnas.96.21.12079. PMID 10518579. Bibcode: 1999PNAS...9612079B.
«An update on GABA analogs for CNS drug discovery». Recent Patents on CNS Drug Discovery 1 (1): 113–8. January 2006. doi:10.2174/157488906775245291. PMID 18221197.
«Gabapentin: pharmacology and its use in pain management». Anaesthesia 57 (5): 451–62. May 2002. doi:10.1046/j.0003-2409.2001.02399.x. PMID 11966555. https://archive.org/details/sim_anaesthesia_2002-05_57_5/page/451.
«Conformationally restricted GABA analogs: from rigid carbocycles to cage hydrocarbons». Future Medicinal Chemistry 3 (2): 223–41. February 2011. doi:10.4155/fmc.10.287. PMID 21428817.
«Once-daily gastroretentive gabapentin for the management of postherpetic neuralgia: an update for clinicians». Therapeutic Advances in Chronic Disease 3 (5): 211–8. September 2012. doi:10.1177/2040622312452905. PMID 23342236.

pubmedcentral.nih.gov

«Gabapentin for chronic neuropathic pain in adults». The Cochrane Database of Systematic Reviews 6: CD007938. June 2017. doi:10.1002/14651858.CD007938.pub4. PMID 28597471.
«Mechanisms of the gabapentinoids and α 2 δ-1 calcium channel subunit in neuropathic pain». Pharmacology Research & Perspectives 4 (2): e00205. April 2016. doi:10.1002/prp2.205. PMID 27069626.
«Gabapentin misuse, abuse and diversion: a systematic review». Addiction 111 (7): 1160–74. July 2016. doi:10.1111/add.13324. PMID 27265421.
«Anticonvulsants in the treatment of low back pain and lumbar radicular pain: a systematic review and meta-analysis». CMAJ 190 (26): E786–E793. July 2018. doi:10.1503/cmaj.171333. PMID 29970367.
«Benefits and safety of gabapentinoids in chronic low back pain: A systematic review and meta-analysis of randomized controlled trials». PLOS Medicine 14 (8): e1002369. August 2017. doi:10.1371/journal.pmed.1002369. PMID 28809936.
«Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials». PLOS ONE 5 (12): e14433. December 2010. doi:10.1371/journal.pone.0014433. PMID 21203440. Bibcode: 2010PLoSO...514433P.
«Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis». The Lancet. Neurology 14 (2): 162–73. February 2015. doi:10.1016/S1474-4422(14)70251-0. PMID 25575710. «There was no evidence for a dose-response effect.».
«Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults». The Cochrane Database of Systematic Reviews 6 (6): CD010609. June 2013. doi:10.1002/14651858.CD010609. PMID 23797675.
«Gabapentin Therapy in Psychiatric Disorders: A Systematic Review». The Primary Care Companion for CNS Disorders 17 (5). 2015. doi:10.4088/PCC.15r01821. PMID 26835178.
«Gabapentin for smoking cessation». Nicotine & Tobacco Research 12 (3): 300–4. March 2010. doi:10.1093/ntr/ntp195. PMID 20081039.
«Pharmacotherapies for cannabis dependence». The Cochrane Database of Systematic Reviews 1: CD008940. January 2019. doi:10.1002/14651858.CD008940.pub3. PMID 30687936.
«Pruritus and renal failure». Seminars in Cutaneous Medicine and Surgery 30 (2): 99–100. June 2011. doi:10.1016/j.sder.2011.04.005. PMID 21767770.
«The treatment of tremor». Neurotherapeutics 11 (1): 128–38. January 2014. doi:10.1007/s13311-013-0230-5. PMID 24142589.
«Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology». Neurology 77 (19): 1752–5. November 2011. doi:10.1212/WNL.0b013e318236f0fd. PMID 22013182.
«Review about gabapentin misuse, interactions, contraindications and side effects». Journal of Experimental Pharmacology 9: 13–21. 2017. doi:10.2147/JEP.S124391. PMID 28223849.
«Gabapentin enacarbil - clinical efficacy in restless legs syndrome». Neuropsychiatric Disease and Treatment 6: 151–8. May 2010. doi:10.2147/NDT.S5712. PMID 20505847.
«The Useage of Opioids and their Adverse Effects in Gastrointestinal Practice: A Review». Middle East Journal of Digestive Diseases 5 (1): 5–16. January 2013. PMID 24829664.
«Molecular determinants of blood-brain barrier permeation». Therapeutic Delivery 6 (8): 961–71. 2015. doi:10.4155/tde.15.32. PMID 26305616.
«Selective expression of the large neutral amino acid transporter at the blood-brain barrier». Proceedings of the National Academy of Sciences of the United States of America 96 (21): 12079–84. October 1999. doi:10.1073/pnas.96.21.12079. PMID 10518579. Bibcode: 1999PNAS...9612079B.
«Once-daily gastroretentive gabapentin for the management of postherpetic neuralgia: an update for clinicians». Therapeutic Advances in Chronic Disease 3 (5): 211–8. September 2012. doi:10.1177/2040622312452905. PMID 23342236.

dailymed.nlm.nih.gov

«Neurontin- gabapentin capsule Neurontin- gabapentin tablet, film coated Neurontin- gabapentin solution». DailyMed. 11 Απριλίου 2019. Ανακτήθηκε στις 21 Δεκεμβρίου 2019.

nursingnotes.co.uk

«Pregabalin and gabapentin will become controlled drugs in April». NursingNotes (στα Αγγλικά). 17 Οκτωβρίου 2018. Αρχειοθετήθηκε από το πρωτότυπο στις 16 Ιουνίου 2019. Ανακτήθηκε στις 16 Ιουνίου 2019.